Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases Research Summary
This study evaluated whether finerenone, a nonsteroidal mineralocorticoid receptor antagonist, can slow loss of kidney function in patients with glomerular diseases.
